| Document |
Document Title |
|
WO/2007/086695A1 |
The present invention provides a novel anthracene derivative, a method for preparing the same, and an organic electronic device using the same. The anthracene derivative according to the invention can function alone as a light emitting h...
|
|
WO/2007/074147A1 |
The present invention relates to a process for reacting an aromatic hydrocarbon containing aromatic sulphur compounds, or a mixture of aromatic hydrocarbons containing aromatic sulphur compounds, where appropriate in the presence of hydr...
|
|
WO/2007/070984A1 |
The present invention relates to spiroketal compounds that are useful in methods of treating or preventing protozoal infections, parasitic infections, bacterial infections, cell proliferative disorders and anti inflammatory disorders. Th...
|
|
WO/2007/072742A1 |
There are provided a compound represented by the general formula (1) and an organic light-emitting device which comprises the compound and has an optical output with remarkably high efficiency and high luminance.
|
|
WO/2007/065548A1 |
The invention relates to blends of organic material, to the use of said blends in organic electroluminescent devices and to organic electroluminescent devices containing said blends.
|
|
WO/2007/065409A2 |
The invention relates to at least dinitroxylated diamantanes, and to methods by which means a high yield and selectivity of substituted diamantanes can be produced. According to the invention, dinitroxylated diamantanes can be reacted wi...
|
|
WO/2007/063974A1 |
Disclosed is a process for hydrogenating an aromatic ring of an aromatic ring compound which proceeds under comparatively mild conditions. This process for hydrogenating an aromatic ring of an aromatic ring compound can be carried out in...
|
|
WO/2007/060484A1 |
The present invention relates to compounds of formula (I); and pharmaceutically acceptable salts thereof and individual enantiomers and diastereomers thereof, as GIyTl inhibitors for treating neurological and psychiatric disorders.
|
|
WO/2007/049293A1 |
A process for the preparation of Irbesartan of formula (I): Formula (I) comprising the steps of: (i) reacting 4' aminomethyl-2-cyano biphenyl of formula (VI) with 1-veleramido cyclopentane carboxylic acid of formula (V): Formula (VI) & F...
|
|
WO/2007/046258A1 |
[PROBLEMS] To provide a method of rapid alkene compound methylation which is applicable to the preparation of a PET tracer and which enables an alkene compound to be rapidly methylated through cross coupling between SP2 (alkenyl) and SP3...
|
|
WO/2007/023739A1 |
Disclosed is a process for production of a cycloolefin comprising the step of performing the partial hydrogenation of a monocyclic aromatic hydrocarbon with hydrogen in the presence of a ruthenium catalyst, water and a metal sulfate to p...
|
|
WO/2007/022845A1 |
The invention relates to compounds of formula (1) and to the use thereof in organic electroluminescent devices. The compounds of formula (1) are used as host material or as a dopant in the emitting layer and/or as hole transport material...
|
|
WO/2007/013469A1 |
Disclosed is a method for producing an (alkylphenyl)alkylcyclohexane comprising a step wherein an alkylbenzene and an alkylcyclohexene or alkylcyclohexanol are condensed in the presence of an acid catalyst. Also disclosed is an (alkylphe...
|
|
WO/2007/003975A1 |
The invention relates to a process for the preparation of perhydroacenaphthene (chemical name: (2aR,5aα,8aR,8bα)-dodecahydro-acenaphthylene) of formula I, by catalytic hydrogenation of acenaphthene of formula II, in which the reaction ...
|
|
WO/2007/004080A1 |
The present invention relates to the use as perfuming ingredient of a 3,3-dimethylbicyclo[2.2.1]hept-2-yl or a 3,3-dimethylbicyclo[2.2.1]hept-5-en-2-yl derivative, as well as to the compositions or articles containing said compound.
|
|
WO/2007/003602A1 |
The invention relates to a method for obtaining cyclododecatriene (CDT) from a solution containing CDT and high-boiling components such as a deactivated catalyst and polymers. Said solution is supplied to a preheater and heated, and is t...
|
|
WO/2006/131192A1 |
The present invention relates to new materials which can be used in organic electronic devices, in particular electroluminescence devices, and which are specific derivates of condensed aromatic systems.
|
|
WO/2006/126608A1 |
A novel fluorene derivative useful as a catalyst ingredient for olefin polymerization; a transition metal compound containing the fluorene derivative as part of ligands; an olefin polymerization catalyst comprising the transition metal c...
|
|
WO/2006/120841A1 |
It is intended to realize storage and transportation of large amounts of energy and to carry out storage or supply of energy in conformity with fluctuation of natural energy. There is provided an organic hydride synthesizing apparatus ca...
|
|
WO/2006/114364A1 |
The invention relates to a method for producing polyfluoroanthenes containing repeat units of general formula (I), said method consisting of the following steps: a) a monomer fluoroanthene derivative of formula IIa is produced; b) option...
|
|
WO/2006/112188A1 |
[PROBLEMS] To provide a method and apparatus for the crystallization of an organic compound through adiabatic cooling, which can attain a reduction in operation and equipment cost. [MEANS FOR SOLVING PROBLEMS] Crystal tanks (20A) and (20...
|
|
WO/2006/112187A1 |
[PROBLEMS] To provide a method and apparatus for the crystallization of an organic compound through adiabatic cooling, which can attain a reduction in operation and equipment cost. [MEANS FOR SOLVING PROBLEMS] In a crystal tank (20), an ...
|
|
WO/2006/112185A1 |
[PROBLEMS] To provide a method and apparatus for the crystallization of an organic compound through adiabatic cooling, which can attain a reduction in operation and equipment cost. [MEANS FOR SOLVING PROBLEMS] In a crystal tank (20), an ...
|
|
WO/2006/112186A1 |
[PROBLEMS] To provide a method and apparatus for the crystallization of an organic compound through adiabatic cooling, which can attain a reduction in operation and equipment cost. [MEANS FOR SOLVING PROBLEMS] In a crystal tank (20), an ...
|
|
WO/2006/109569A1 |
The invention provides terphenylene derivatives which have excellent oxidation resistance and permit the formation of semiconductor active phases by coating; and oxidation-resistant organic semiconductor materials and organic thin films,...
|
|
WO/2006/099762A1 |
A method of providing a cooling sensation to the skin or the mucous membranes of the body by applying thereto a compound of Formula (I) in which X is H or (CH2)n-R, n is 0 or 1, Y and Z are selected independently from the group consistin...
|
|
WO/2006/090098A1 |
An electroluminescent compound is a diarylamine anthracene compound.
|
|
WO/2006/085628A1 |
Disclosed is a method for producing a compound (D) through coupling by subjecting an organic compound (A) having a leaving group and an organic metal compound or metal hydride compound (B) to a coupling reaction. This method is character...
|
|
WO/2006/073270A1 |
Provided are a photoreactive polymer that includes a multi-cyclicmulticyclic compound at as its main chain and a method of preparing the same. The photoreactive polymer exhibits excellent thermal stability since it includes a multi-cycli...
|
|
WO/2006/070848A1 |
Disclosed is a polymer compound characterized by containing a structure represented by the following formula (1).(In the formula, ring A and ring B independently represent an optionally substituted aromatic hydrocarbon ring, and ring C r...
|
|
WO/2006/067483A1 |
A process is provided for the synthesis of a compound of formula (1) wherein m=0 or 1; n and p are 0 or 1 to 4; X is a single bond, O, S or NH; and R1 - R4 are as defined in claim 1.
|
|
WO/2006/048750A2 |
The present invention relates to compounds with the formula (I) or a pharmaceutically acceptable salt thereof: The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a co...
|
|
WO/2006/035997A1 |
Provided is a novel compound that can be suitably used as a compound for an organic EL device. The compound is represented by general formula (1): wherein x, y and z are an integer of 0 to 3 with x + z ≥ 1; R3, R15, R16, R17, and R18 a...
|
|
WO/2006/023572A1 |
A basestock that comprises a fully hydrogenated substituted styrene linear dimer; a partially hydrogenated mono-aromatic substituted styrene linear dimer; and a partially hydrogenated di-aromatic substituted styrene linear dimer. A proce...
|
|
WO/2006/011873A1 |
This invention provides a process for forming monomers from a dimer, wherein the dimer is dicyclopentadiene, di(methylcyclopentadiene), di(ethyleyclopentadiene), or a mixture of any two or more of these. The process comprises i) heating ...
|
|
WO/2006/008998A1 |
A method in which either adamantane purified with a naphthenic solvent is regulated so as to have a solvent content of 0.35 mass% or lower or adamantane purified with a solvent other than naphthenic solvents is regulated so as to have a ...
|
|
WO/2006/009346A2 |
The present invention provides a novel method for highly selective preparation of 2,6-dialkyltetralin, a key precursor for 2,6-dimethylnaphthalene (2,6-DMN), which does not require an extra step for purifying various isomers obtained fro...
|
|
WO/2006/006277A1 |
A catalyst for cycloolefin production by the partial hydrogenation of a monocyclic aromatic hydrocarbon, the catalyst comprising zirconia as a support and being constituted of particles having an average primary-particle diameter in the ...
|
|
WO/2006/005626A2 |
The invention relates to novel truxene and isotruxene derivatives, particularly spirocyclic truxene derivatives and spirocyclic isotruxene derivatives, and the use thereof in organic electronic devices, especially organic electroluminesc...
|
|
WO/2006/000043A1 |
The invention provides a compound of the formula (I): wherein R is methyl, ethyl, propyl, isopropyl, butyl, pentyl, neo-pentyl or cyclohexyl, or a salt or solvate thereof. These compounds are selective GABAC receptor antagonists. The inv...
|
|
WO/2006/001333A1 |
Disclosed are a novel polycyclic aromatic compound having a specific structure and a material for forming a luminescent coating film which is composed of an organic solvent solution containing such a polycyclic aromatic compound. Also di...
|
|
WO/2005/123634A1 |
Disclosed is a fluorene derivative having a specific structure. Also disclosed is an organic electroluminescent device having high luminous efficiency wherein an organic thin film layer composed of one or more layers including at least a...
|
|
WO/2005/121057A1 |
Disclosed is an anthracene derivative having a specific asymmetric structure. Also disclosed is an organic electroluminescent device wherein an organic thin film layer composed of one or more layers including at least a light-emitting la...
|
|
WO/2005/115950A1 |
Disclosed are asymmetric pyrene derivatives having a specific structure. An organic electroluminescent device comprising an organic thin film layer which is interposed between an anode and a cathode and composed of one or more layers inc...
|
|
WO/2005/092906A1 |
The invention relates to novel hyperbranched molecules, the structure of which incorporates metals known as metalodendrites, having a conformation which changes in a reversible manner in response to a redox stimulus, and to the use of sa...
|
|
WO/2005/082817A1 |
An industrially advantageous process for producing adamantane by which high-purity adamantane reduced in coloration is efficiently produced while minimizing the loss. The process, which is for producing adamantane by isomerizing trimethy...
|
|
WO/2005/075398A1 |
A novel calixarene compound which is expected to be used as a clathrate compound and which, after incorporation of a functional group thereinto, is usable in curable compositions or photoresists or as a clathrate compound. The calixarene...
|
|
WO/2005/070913A1 |
Most carbon-centered free radical antioxidants are generated through hydrogen abstraction. Disclosed herein are a new class of antioxidant precursor compounds of the formula A-B, wherein upon exposure of the compounds to an increase in t...
|
|
WO/2005/065243A2 |
Novel compounds having a hybrid cubic/hexagonal diamond crystal structure are disclosed. Each of the four compounds have the stoichiometric formula C26H32 and a molecular weight of 344. The four compounds are contemplated to have a utili...
|
|
WO/2005/058916A2 |
The present invention relates to organometallic transition metal compounds of formula (I) where M1, X, n, Z, R1-R8 and A are as defined in the claims, biscyclopentadienyl ligand systems having such a substitution pattern, catalyst system...
|
